Direkt zum Inhalt
Merck

Portal-systemic encephalopathy and hepatic coma.

The Medical clinics of North America (1986-09-01)
D M Jensen
ZUSAMMENFASSUNG

Decompensation in the cirrhotic patient is typically manifested as hepatic encephalopathy or coma. This may be precipitated by azotemia, gastrointestinal bleeding, infection, hypokalemic alkalosis, excess dietary protein, or the use of sedative, tranquilizer, or analgesic medications. The pathogenesis of hepatic encephalopathy associated with portal-systemic shunting is unknown, but theories purporting major roles for ammonia, AAAs, false neurotransmitters, and GABA have been advanced. Treatment is aimed at removing precipitating factors and eliminating nitrogenous substances from the gastrointestinal tract.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
Fluopyram, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland